IMA ART Fertility Defines a New Standard of Discretion, Governance, and Emotional Intelligence in Luxury Surrogacy BEVERLY HILLS, CALIFORNIA / ACCESS Newswire / November 15, 2025 / Before 2022, "boutique surrogacy agency" was not part of the fertility lexicon. The field focused on logistics and outcomes, not refined experience or emotional intelligence. That changed when […]
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE:MOH).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against RCI Hospitality Holdings, Inc. ("RCI" or the "Company") (NASDAQ:RICK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Primo Brands Corporation ("Primo Brands" or the "Company") (NYSE:PRMB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Quanex Building Products Corporation ("Quanex" or the "Company") (NYSE:NX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010,
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avantor, Inc. ("Avantor" or the "Company") (NYSE:AVTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by